Personalized cancer treatment based on your medical profile
Part of Cancer clinical trials.
This trial is studying a way to help guide individualized cancer treatment using your existing medical information. If you receive cancer care at the specific study sites, you may be able to enroll.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Currently receiving care for cancer, or have received care for cancer before
- Receive your cancer care at MCW or FH (the study sites)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This study uses a personalized cancer treatment plan and looks at how well it works and side effects. You may be able to join if you (or your parent/guardian, if needed) are willing to consent to the study.
This Phase 2 study uses a team review of your tumor’s gene test results to help match you with treatments you may benefit from. It’s designed for people whose tumor has specific gene changes that suggest sensitivity to available medicines or may involve inherited (germline) risk.
This study collects evidence on personalized (“targeted”) cancer treatments for adults with rare cancers or rare tumor changes. If you may qualify, it may help make these treatments more widely available in the future by studying how well they work and how patients feel.
This trial is a low-risk cancer prevention study that enrolls adults to help support healthier choices and early prevention efforts. It may help you stay on track with prevention guidance through participating healthcare programs.
This trial studies how doctors choose individualized cancer treatment for people with pancreatic cancer. It may help them learn which treatment choices work best for different patients.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.